Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132808) titled 'Predictive Study of Embolization Efficacy for NELM Using Quantitative Imaging Parameters' on Sept. 18.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

Condition: neuroendocrine liver metastases (NELM)

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-10-01

Target Sample Size: Observation group:150;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=341694

Published by HT Digital Content Services with permission from Health Daily Diges...